Attached files

file filename
EX-31.2 - EX-31.2 - ENDOCYTE INCf59167exv31w2.htm
EX-10.1 - EX-10.1 - ENDOCYTE INCf59167exv10w1.htm
EX-10.2 - EX-10.2 - ENDOCYTE INCf59167exv10w2.htm
EX-31.1 - EX-31.1 - ENDOCYTE INCf59167exv31w1.htm
10-Q - FORM 10-Q - ENDOCYTE INCf59167e10vq.htm
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
     I, P. Ron Ellis, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Endocyte, Inc. on Form 10-Q for the quarter ended March 31, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Endocyte, Inc. for the periods covered by such Quarterly Report on Form 10-Q.
         
     
May 13, 2011 By:  /s/ P. Ron Ellis  
(Date)   Name:   P. Ron Ellis   
    Title:   President and Chief Executive Officer   
 
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
     I, Michael A. Sherman, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Endocyte, Inc. on Form 10-Q for the fiscal year ended March 31, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Endocyte, Inc. for the periods covered by such Quarterly Report on Form 10-Q.
         
     
May 13, 2011 By:   /s/ Michael A. Sherman  
(Date)   Name:   Michael A. Sherman   
    Title:   Chief Financial Officer